GEVO · Gevo, Inc. - Financials
Annual line items from SEC XBRL filings, sourced from EDGAR's Company Facts API with fallback to the quarterly Financial Statement Data Sets. See issuer overview for Form 4 activity and 10-K signals.
Income Statement
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $160.58M | $16.91M | $17.20M | $533.0K | $711.0K | $5.54M |
| Cost of Revenue | - | - | - | - | - | $15.00M |
| Gross Profit | - | - | - | - | ($11.45M) | ($9.47M) |
| R&D | $4.55M | $5.58M | $6.64M | $7.43M | $6.78M | $4.09M |
| SG&A | $51.20M | $45.80M | $42.63M | $25.49M | $25.49M | $12.53M |
| Total Operating Expenses | $180.79M | $107.74M | $99.03M | $60.80M | $48.64M | $16.87M |
| D&A | $12.90M | $18.30M | $19.01M | $7.89M | $5.13M | $5.88M |
| Operating Income | ($20.21M) | ($90.82M) | ($81.83M) | ($102.69M) | ($60.09M) | ($26.34M) |
| Interest Expense | $17.56M | $3.88M | $2.16M | $1.17M | $2.09M | $2.09M |
| Income Tax | - | - | - | - | - | $0 |
| Net Income | ($33.84M) | ($78.64M) | ($66.22M) | ($98.01M) | ($59.20M) | ($40.19M) |
| EPS - Basic | ($0.14) | ($0.34) | ($0.28) | ($0.44) | - | - |
| EPS - Diluted | ($0.14) | ($0.34) | ($0.28) | ($0.30) | - | - |
Balance Sheet
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $81.16M | $189.39M | $298.35M | $237.13M | $40.83M | $78.34M |
| Accounts Receivable | $8.39M | $2.41M | $2.62M | $476.0K | $978.0K | $527.0K |
| Inventory | $19.08M | $4.50M | $3.81M | $6.35M | $2.75M | $2.26M |
| Accounts Payable | $1.08M | $539.0K | $2.72M | $5.01M | $4.87M | $897.0K |
| Current Assets | $143.40M | $203.71M | $386.38M | $415.42M | $351.79M | $83.27M |
| Total Assets | $718.93M | $583.94M | $650.32M | $700.75M | $666.48M | $152.10M |
| Current Liabilities | $78.58M | $24.36M | $91.43M | $25.44M | $32.63M | $4.93M |
| Long-term Debt | $164.75M | $67.11M | $21.0K | $67.38M | $66.80M | - |
| Total Liabilities | $247.76M | $94.45M | $92.93M | $95.27M | $119.22M | $5.72M |
| Stockholders' Equity | $466.34M | $489.49M | $557.39M | $605.48M | $547.25M | $146.38M |
| Retained Earnings | ($834.15M) | ($800.24M) | ($721.60M) | ($655.38M) | ($557.38M) | ($498.17M) |
Cash Flow
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | ($13.40M) | ($57.38M) | ($53.72M) | ($52.61M) | ($43.54M) | ($19.34M) |
| Investing Cash Flow | ($226.57M) | ($51.82M) | $114.13M | $93.39M | ($411.62M) | ($5.91M) |
| Financing Cash Flow | $97.88M | ($7.36M) | ($189.0K) | $138.56M | $512.85M | $87.28M |
| CapEx | $30.11M | $51.09M | $54.45M | $75.78M | $94.78M | $5.91M |
| Free Cash Flow | ($43.51M) | ($108.47M) | ($108.17M) | ($128.39M) | ($138.32M) | ($25.24M) |
Ratios
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Profitability | ||||||
| Gross margin | - | - | - | - | -1611.0% | -171.0% |
| Operating margin | -12.6% | -536.9% | -475.8% | -19265.7% | -8451.5% | -475.7% |
| EBITDA margin | -4.6% | -428.8% | -365.3% | -17785.9% | -7730.2% | -369.5% |
| Net margin | -21.1% | -464.9% | -385.0% | -18387.8% | -8326.7% | -725.9% |
| Free cash flow margin | -27.1% | -641.3% | -628.9% | -24087.8% | -19453.9% | -456.0% |
| FCF / Net income | 1.29 | 1.38 | 1.63 | 1.31 | 2.34 | 0.63 |
| R&D / Revenue | 2.8% | 33.0% | 38.6% | 1393.4% | 952.9% | 73.8% |
| SG&A / Revenue | 31.9% | 270.8% | 247.8% | 4782.9% | 3585.5% | 226.3% |
| Effective tax rate | - | - | - | - | - | - |
| Return on assets | -4.7% | -13.5% | -10.2% | -14.0% | -8.9% | -26.4% |
| Return on equity | -7.3% | -16.1% | -11.9% | -16.2% | -10.8% | -27.5% |
| Return on invested capital | - | - | - | - | - | - |
| Liquidity | ||||||
| Current ratio | 1.82 | 8.36 | 4.23 | 16.33 | 10.78 | 16.88 |
| Quick ratio | 1.58 | 8.18 | 4.18 | 16.08 | 10.70 | 16.43 |
| Cash ratio | 1.03 | 7.77 | 3.26 | 9.32 | 1.25 | 15.88 |
| Leverage | ||||||
| Debt / Equity | 0.35 | 0.14 | 0.00 | 0.11 | 0.12 | - |
| Debt / Assets | 0.23 | 0.11 | 0.00 | 0.10 | 0.10 | - |
| Debt / EBITDA | - | - | - | - | - | - |
| Interest coverage | -1.2x | -23.4x | -37.9x | -88.0x | -28.7x | -12.6x |
| Equity multiplier | 1.54 | 1.19 | 1.17 | 1.16 | 1.22 | 1.04 |
| Liabilities / Assets | 0.34 | 0.16 | 0.14 | 0.14 | 0.18 | 0.04 |
| Efficiency | ||||||
| Asset turnover | 0.22 | 0.03 | 0.03 | 0.00 | 0.00 | 0.04 |
| Inventory turnover | - | - | - | - | - | 6.65 |
| Days sales outstanding | 19d | 52d | 56d | 326d | 502d | 35d |
| Days inventory outstanding | - | - | - | - | - | 55d |
| Days payable outstanding | - | - | - | - | - | 22d |
| Cash conversion cycle | - | - | - | - | - | 68d |
| Valuation | ||||||
| P / E | - | - | - | - | - | - |
| P / B | 1.0x | 1.0x | 0.5x | 0.6x | - | - |
| P / S | 2.9x | 28.6x | 16.1x | 698.0x | - | - |
| EV / EBITDA | - | - | - | - | - | - |
| Growth | ||||||
| Revenue growth (YoY) | 849.3% | -1.7% | 3127.0% | -25.0% | -87.2% | -77.4% |
| Revenue CAGR (3y) | 570.4% | 187.6% | 45.9% | -72.1% | -72.1% | -41.4% |
| Revenue CAGR (5y) | 96.1% | -7.1% | -12.1% | -54.6% | -51.8% | -28.7% |
| Gross profit growth (YoY) | - | - | - | - | -21.0% | 22.7% |
| Operating income growth (YoY) | 77.7% | -11.0% | 20.3% | -70.9% | -128.2% | 0.1% |
| Net income growth (YoY) | 57.0% | -18.8% | 32.4% | -65.5% | -47.3% | -40.2% |
| EPS growth (YoY) | 58.8% | -21.4% | 6.7% | - | - | - |
| EPS CAGR (3y) | - | - | - | - | - | - |
| EPS CAGR (5y) | - | - | - | - | - | - |
| FCF growth (YoY) | 59.9% | -0.3% | 15.7% | 7.2% | -447.9% | 5.9% |
| FCF CAGR (5y) | - | - | - | - | - | - |
| Book value growth (YoY) | -4.7% | -12.2% | -7.9% | 10.6% | 273.9% | 101.9% |
Sales by segment
From XBRL dimensional facts in the 10-K period ending 2025-12-31.
Business segments
$160.58M totalGevo North Dakota Segment$136.78M · 85.2%
Renewable Natural Gas Segment$18.05M · 11.2%
Gevo Segment$5.75M · 3.6%
Stability scores
Altman Z′
FY 2025 · bankruptcy risk
0.01
Distress
Private-firm variant - uses book equity instead of market cap. > 2.90 safe · 1.23-2.90 grey · < 1.23 distress.
Piotroski F-score
FY 2025 · 9-point quality
3/9
Weak
- ✗Net income positive
- ✗Operating cash flow positive
- ✓ROA improved YoY
- ✓Cash flow > net income
- ✗Long-term debt decreased
- ✗Current ratio improved
- ✗No share dilution
- -Gross margin improved
- ✓Asset turnover improved
Peer comparison
Same SIC group: Industrial Organic Chemicals
Comparing Gevo against the 5 most active filers in the same SIC group.